While HMPV can cause severe lung infections in vulnerable people, it doesn't have the high death rate seen in severe Covid-19 cases. Most HMPV infections are mild, so healthcare systems can ...

EXCLUSIVE: Possibly the closest the world has come to experiencing Covid-19-style lockdowns in the five years since is when ...

Human metapneumovirus (HMPV), although discovered in 2001, is making headlines after an unspecified increase in cases was reported in China. Although it has not been officially pronounced by local ...

Cases of human metapneumovirus (hMPV) are rising in the UK, weeks after images of packed hospital waiting rooms in China sparked alarm on social media. It was dubbed the “mystery virus” as ...

There is no evidence that post-mortem samples were taken from a premature baby after his death, a hospital boss has said. Documents appear to suggest that four samples were sent for testing following ...

First reported in children from the Netherlands in 2001. Retrospective studies have shown the presence of human metapneumovirus (HMPV) in the human population from as early as the 1950s.

The incubation period for HMPV is usually between three and six days, with symptoms lasting for varying durations depending on the severity of the infection ...

(Background image: People wearing protective face masks as a preventive measure against the spread of HMPV in India/Right image: Prof Sarath Ranganathan, a Melbourne-based expert in respiratory ...

Ghana has recorded one case of Human Metapneumovirus (hMPV). This is the first case detected since the country begun testing for human metapneumovirus hMPV in January 2025. Mr Kwabena Mintah Akandoh, ...

People in the UK have been advised to avoid some medical settings and to wear masks in some hospitals and clinics after a rise in cases of a virus now as HMPV. Infections caused concern when there ...

We’ve seen increased interest in recent weeks in the number of cases of respiratory illness caused by the human metapneumovirus, also known as hMPV. Some headlines have referred to a “mystery virus”, ...

hVIVO plc (AIM: HVO), a fast-growing early-stage Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that, following the success of its pilot human ...